The hERG Cardiac Potassium Channel
Structure, Function and Long QT Syndrome, Novartis Foundation Symposium
It features regulatory authority perspectives on preferred preclinical test systems and includes topics on hERG channel gating, regulation of functional expression, pharmacological properties of hERG/IKr channels, drug-induced long QT syndrome and preclinical evaluation and regulatory recommendations for assessing QT prolongation risks.
Better understanding of the role of the hERG channel in drug-induced cardiac arrhythmias should ultimately lead to the development of important, new and safer medicines.
Title: The hERG Cardiac Potassium Channel
Author: Novartis Foundation